| P50 | author | Yubo Li | Q57542901 |
| | Yanyan Xu | Q89618943 |
| | Yanjun Zhang | Q90845367 |
| P2093 | author name string | Xuejun Guo | |
| | Yiwei Zhao | |
| P2860 | cites work | Inflammation and resolution are associated with upregulation of fatty acid β-oxidation in Zymosan-induced peritonitis | Q27314814 |
| | International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature | Q28201589 |
| | Phosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effects | Q28482353 |
| | Essential role for sphingosine kinases in neural and vascular development | Q28505987 |
| | Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids | Q30617789 |
| | A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease. | Q30708048 |
| | Mass spectrometry in plant metabolomics strategies: from analytical platforms to data acquisition and processing | Q30786453 |
| | Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients | Q33345474 |
| | Metabonomic study of Chinese medicine Shuanglong formula as an effective treatment for myocardial infarction in rats | Q33751434 |
| | Pharmaco-metabonomic phenotyping and personalized drug treatment | Q34515169 |
| | NMR-based metabolomics approach to study the toxicity of lambda-cyhalothrin to goldfish (Carassius auratus). | Q35056902 |
| | UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry | Q35217999 |
| | Metabonomic Evaluation of Chronic Unpredictable Mild Stress-Induced Changes in Rats by Intervention of Fluoxetine by HILIC-UHPLC/MS. | Q35665100 |
| | Nutritional metabonomics: applications and perspectives | Q36725142 |
| | Metabolomics for phytomedicine research and drug development | Q37079380 |
| | Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy? | Q37634989 |
| | NMR metabolomics of human blood and urine in disease research | Q38214023 |
| | Microglia and neuroprotection | Q38360452 |
| | Dose responsive effects of cisplatin in L02 cells using NMR-based metabolomics | Q39045048 |
| | Oxaliplatin-induced oxidative stress in nervous system-derived cellular models: could it correlate with in vivo neuropathy? | Q39172500 |
| | Acute oxaliplatin-induced peripheral nerve hyperexcitability | Q39408791 |
| | A Systematic Strategy for Screening and Application of Specific Biomarkers in Hepatotoxicity Using Metabolomics Combined With ROC Curves and SVMs | Q40092878 |
| | Screening, verification, and optimization of biomarkers for early prediction of cardiotoxicity based on metabolomics | Q41005391 |
| | The effect of curcumin on oxaliplatin and cisplatin neurotoxicity in rats: some behavioral, biochemical, and histopathological studies | Q42000475 |
| | Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease | Q46939823 |
| | Phase II study of an oxaliplatin/vinorelbine combination in patients with anthracycline- and taxane-pre-treated metastatic breast cancer. | Q46978072 |
| | Membrane fusion and vesicular transformation induced by Alzheimer's amyloid beta. | Q53122637 |
| | A urinary metabolomics study of rats after the exposure to acrylamide by ultra performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry. | Q53606641 |
| | Understanding 'Global' Systems Biology: Metabonomics and the Continuum of Metabolism | Q56453763 |
| | Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin | Q63282725 |
| | Screening and validation for plasma biomarkers of nephrotoxicity based on metabolomics in male rats | Q90844032 |
| P433 | issue | 3 | |
| P921 | main subject | oxaliplatin | Q422327 |
| | multivariate statistics | Q1952580 |
| | neurotoxicity | Q3338704 |
| | toxic encephalopathy | Q7830379 |
| | metabolic profiling | Q116909045 |
| P304 | page(s) | 529-537 | |
| P577 | publication date | 2018-04-27 | |
| P1433 | published in | Toxicology research | Q26853990 |
| P1476 | title | Plasma metabolic profiling analysis of neurotoxicity induced by oxaliplatin using metabonomics and multivariate data analysis | |
| P478 | volume | 7 | |